Partnership to deliver integrated, off-the-shelf biosimilar manufacturing solutions
Pall and Aetos to advance the market impact of biosimilars and deliver lower-priced, high-quality options to end users.
Customers set to benefit from access to integrated solutions for expedited biosimilars development.
The companies will collaborate to offer biosimilar manufacturing solutions to the global biosimilars market. Pall Biotech will provide access to next generation bioprocess equipment, such as the Allegro STR Single-use Stirred Tank Bioreactor for GMP manufacturing, and consumables to enable efficient biosimilar production. Aetos Biologics will provide high-quality/high-titer cell lines, and scalable manufacturing processes.
“Biosimilars are a replication of a successful biopharmaceutical product. While they are much less expensive than innovator molecules, the complexities in their development make it critical to work with the right equipment and service providers,” said Mario Philips, VP & General Manager at Pall Biotech. “We are excited to partner with the Aetos Biologics team to advance the market impact of biosimilars and deliver lower-priced, high-quality options to end users.”
“Our team is constantly working to optimize a growing pipeline of high-yield biosimilars with outstanding quality,” said Amita Goel, founder and CEO of Aetos Biologics. “Through this strategic partnership with Pall Biotech, we can ensure that the exceptional quality we achieve in scaled-up processes is efficiently transferred and reproduced by the client.”
By aligning Pall Biotech equipment, including bioreactors, mixing and storage, and downstream technologies with Aetos Biologics’ cell lines and manufacturing processes, customers benefit from access to integrated solutions for expedited biosimilars development.
Related News
-
News Moderna to buy OriCiro Genomics in USD $85 million deal
Pharmaceutical company Moderna acquires genomics services company OriCiro Genomics, based in Tokyo, Japan, to boost mRNA therapeutics development and manufacturing portfolio. -
News New year, new prices: at least 350 drugs in USA to see price increases in January
Drugmakers such as Pfizer, GSK, BMS, AstraZeneca, and Sanofi are planning to raise prices for at least 350 unique drugs in the United States in early January. -
Sponsored Content 2023 Pharma Trend Outlook: Innovation, Resilience, and Pharma 4.0
Download our 2023 Pharma Trends Outlook report to discover the trends set to shape the pharmaceutical landscape in the new year, with expert opinions and insight from across the pharmaceutical value chain. -
News Strategic partnership between AstraZeneca and G42 Healthcare to increase pharmaceutical manufacturing in Abu Dhabi
A comprehensive, long-term partnership agreement between AstraZeneca and G42 Healthcare is set to enhance local drug manufacturing in Abu Dhabi, UAE, and bolster pharmaceutical manufacturing innovation within the country. -
News CordenPharma joins sustainability initiative to achieve Net Zero
The CDMO has joined the environmental initiative looking to align private sector companies with those aims upheld by the Paris Agreement to reduce global warming. -
News AstraZeneca acquires Neogene in shift into cell-based cancer therapies
AstraZeneca has recently announced that it will be acquiring the biotechnology company Neogene Therapeutics as part of it’s expansion into cell-based cancer treatments.
-
News A mRNA universal flu vaccine is in early stages of development
Researchers from the University of Pennsylvania have developed a universal flu vaccine using nanoparticle encapsulated mRNA. -
News Biovac partnership to increase African vaccine manufacturing capabilities
South African biopharma company Biovac signs a partnership deal with the International Vaccine Institute to develop and manufacture an oral cholera vaccine for both the African and global market.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance